Related Experiment Video
Updated: Jul 4, 2026
06:52
Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
In vitro assays for assessing the potential for copper complexes to function as radiopharmaceutical agents
P J Barnard1, S R Bayly, J P Holland
1Siemens Oxford Molecular Imaging Laboratory, Inorganic Chemistry Laboratory, University of Oxford, Oxford, UK. peter.barnard@chem.ox.ac.uk
Summary
New in vitro chemical assays rapidly assess copper(II) radiopharmaceutical stability. These methods predict in vivo behavior by evaluating ligand dissociation and redox challenges, crucial for drug development.
Area of Science:
- Radiopharmaceutical Chemistry
- Inorganic Chemistry
- Biomedical Assays
Background:
- Developing novel copper(II)-based radiopharmaceuticals requires understanding their in vivo stability and biological interactions.
- Assessing the behavior of radiopharmaceutical agents in biological systems is critical for predicting their efficacy and safety.
Purpose of the Study:
- To describe a series of in vitro chemical assays for the rapid initial assessment of copper(II) radiopharmaceutical agents.
- To evaluate the in vivo stability and biological behavior of potential new copper(II)-based radiopharmaceutical agents.
Main Methods:
- Utilizing chemical challenges with cysteine, glutathione (GSH), and histidine to model in vivo S- and N-donor interactions and assess ligand dissociation.
- Performing redox challenge experiments using cysteine, GSH, and ascorbic acid to evaluate copper(II) to copper(I) species stability.
- Conducting stability assessments in human serum, including challenges with serum proteins like thioredoxin and albumin.
- Investigating complex stability and speciation across a range of pH values.
Main Results:
- The assays provide a measure of copper(II) ion loss due to ligand dissociation under various chemical challenges.
- Redox stability of copper(I) species was evaluated, highlighting its importance for biodistribution and excretion.
- Serum stability experiments offered insights into the probable fate of complexes in vivo.
- pH-dependent speciation studies provided data relevant to potential biodistribution.
Conclusions:
- The described in vitro assays offer a rapid and effective method for the initial screening of copper(II) radiopharmaceutical candidates.
- These chemical stability assessments are crucial for predicting the in vivo performance, biodistribution, and pharmacokinetic profiles of radiopharmaceuticals.
- The study provides a framework for evaluating the potential of new copper(II) complexes as radiopharmaceutical agents.
